Novo Nordisk boss ‘surprised’ by European demand for weight-loss drugs
Novo Nordisk has found a “very high willingness” among Europeans to pay for weight-loss drugs, the Danish drugmaker’s chief executive has said. In an interview with the Financial Times, Lars…